StreetAlpha.app
Home › Stocks › KMTS

Kestra Medical Technologies, Ltd. (KMTS)

$28.27
▲ +1.07%
LAST CLOSE · NOV 17

Kestra Medical Technologies makes the ASSURE wearable defibrillator and a connected monitoring platform for heart patients. It last closed at $28.27 on Nov 17, up 1.07% on the day. KMTS reports earnings on Thu, Dec 10, 2026.

AI Auto Pilots
Is KMTS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$106.7M
+60.7% vs a year ago
Net income
−$149.9M
−140.4% margin
EPS (diluted)
−$2.68
Free cash flow
−$122.8M
−115.0% margin
Valuation
Market cap
$1.7B
59.6M shares
P/E
–
No P/E while losing money
Price to sales
15.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$68.6M
At Jul 31
Debt
$72.5M
At Jul 31
Shares outstanding
59.6M
At Sep 11
Fiscal year endsApril
ExchangeNasdaq
Financials history
FY2024: $27.8M$27.8MFY2024FY2025: $59.8M$59.8MFY2025FY2026: $95.1M$95.1MFY2026

From KMTS's SEC filings, latest 10-Q for the period ending Jul 31, 2026 (filed Sep 14). Last 12 months adds up the four latest quarters.

Next report
Dec 10
2026 · Time not announced
Consensus EPS forecast
-$0.61
$32.1M revenue est.
Year-ago EPS
-$0.45
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated KMTS in the past 90 days, not enough for a consensus
Average 12-month target
$32.00
▲ 13.2% upside

Based on 1 analyst who set a price target on KMTS in the past 90 days. The average target is $32.00, with a high of $32.00 and a low of $32.00, compared with the last close of $28.27.

Low $32.00Avg $32.00High $32.00
Blue marker: last close $28.27
Highest target$32.00
Average target$32.00
Lowest target$32.00
Latest rating changes
BTIGReiterated
Sep 2Buy$32
JP MorganInitiated
Aug 10Buy$30
DateFirmActionRatingPrice target
Sep 2BTIGReiteratedBuy$32
Aug 10JP MorganInitiatedBuy$30
Loading…

Technical Analysis

KMTS · as of the Nov 17 close · updated after every close
Moving sideways

The stock sits between its 20 and 50 day averages. It is 15% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 48). The nearest support is the Pivot at $28.16, and the nearest resistance the Pivot R1 at $28.72.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.4%/day
Key levels
$31.9852 week high+13.1%
$29.2720 day average+3.5%
$28.75Swing high (Aug 11)+1.7%
$28.72Pivot R1+1.6%
$28.27Last close
$28.16Pivot−0.4%
$27.90Swing low (Nov 5)−1.3%
$27.71Pivot S1−2.0%
$27.4950 day average−2.8%
$26.49100 day average−6.3%
$24.11200 day average−14.7%
$17.3452 week low−38.7%
Indicators
RSI (14)48.29Middle of its rangeNeutral
MACD0.30Below its signal lineBearish
Stochastic14.0Near the bottom of its rangeOversold
ADX (14)17.6No clear trend
Williams %R-84.5Oversold below −80, overbought above −20Oversold
CCI (20)-103.6Oversold below −100, overbought above 100Oversold
Rate of change−2.5%Change over 10 sessionsBearish
ATR (14)$1.80Typical daily range, 6.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for KMTS

What happened before

See how KMTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in KMTS in the last 90 days.

Loading…

See today’s whale options flow across the market →

KMTS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲65 buying vs 40 selling
  • ●Held by funds +0.2 pts
  • ▲Funds holding +13
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding122109+11.9%
In funds' top 10440.0%
Held by funds98.9%98.7%+0.2 pts
New / increased23 / 4214 / 54−4.4%
Reduced / sold out30 / 1020 / 8+42.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KMTS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KMTS is in one of them and how their past KMTS trades turned out.

KMTS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KMTS in an article yet. Here's the latest on the wider market.

About Kestra Medical Technologies

Kestra Medical Technologies is a medical device and digital health company based in Kirkland, Washington. It makes the ASSURE wearable cardioverter defibrillator, which is worn by patients at elevated risk of sudden cardiac arrest during recovery from heart problems. The company also offers a connected platform with a patient app, remote monitoring software for clinicians, and alert services that notify care teams when a shock is delivered. Its customers are patients and the healthcare providers who manage their cardiac care in the United States.

Headquarters
Kirkland, WA